KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbCellera Biologics (ABCL) Debt Ratio (2020 - 2025)

AbCellera Biologics filings provide 6 years of Debt Ratio readings, the most recent being 0.01 for Q1 2025.

  • Quarterly Debt Ratio fell 81.44% to 0.01 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was 0.01 through Mar 2025, down 81.44% year-over-year, with the annual reading at 0.01 for FY2024, 82.48% down from the prior year.
  • Debt Ratio hit 0.01 in Q1 2025 for AbCellera Biologics, up from 0.01 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.04 in Q2 2023 and bottomed at 0.01 in Q4 2024.
  • Average Debt Ratio over 5 years is 0.02, with a median of 0.02 recorded in 2021.
  • The largest annual shift saw Debt Ratio soared 113.92% in 2022 before it tumbled 82.48% in 2024.
  • AbCellera Biologics' Debt Ratio stood at 0.02 in 2021, then surged by 64.96% to 0.03 in 2022, then grew by 18.22% to 0.03 in 2023, then plummeted by 82.48% to 0.01 in 2024, then grew by 9.78% to 0.01 in 2025.
  • Per Business Quant, the three most recent readings for ABCL's Debt Ratio are 0.01 (Q1 2025), 0.01 (Q4 2024), and 0.01 (Q3 2024).